US 7306799
Use of VEGF inhibitors for treatment of eye disorders
granted A61KA61K38/00A61K38/179
Quick answer
US patent 7306799 (Use of VEGF inhibitors for treatment of eye disorders) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/00, A61K38/179